Advertisements

Bromadine-DM

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Bromadine-DM

Quick Facts

Property Description
Active ingredient Brompheniramine, Dextromethorphan, Pseudoephedrine
Form Oral liquid (syrup), Tablet, Capsule
Pharmacological class Antihistamine/Antitussive/Decongestant Combination
Common use Relief of upper respiratory and allergy symptoms
Origin Synthetic (Chemically synthesized compounds)

What Type of Medicine is Bromadine-DM?

Bromadine-DM is fundamentally defined as a fixed-dose triple-combination product administered via the oral route for the systemic management of upper respiratory symptoms and allergies. It is categorized within the pharmacological class of Antihistamine/Antitussive/Decongestant Combinations, a therapeutic strategy clinically recognized for managing the multisymptom presentation of the common cold. This classification confirms that the medicine provides an integrated approach to managing various symptoms simultaneously. This formulation is often differentiated from single-entity cold remedies by providing three distinct actions in one dose, commonly supplied as an oral liquid (syrup), or in solid dosage forms such as a tablet or capsule.

Bromadine-DM Composition: Identifying the Three Active Components

The composition of Bromadine-DM is established by its three active ingredients: Brompheniramine Maleate, Dextromethorphan Hydrobromide (Dextromethorphan HBr), and Pseudoephedrine. These active components are chemically synthesized organic compounds, classifying the drug as having a synthetic origin. This specific triple-combination includes a first-generation antihistamine (Brompheniramine), a non-narcotic antitussive (Dextromethorphan), and a sympathomimetic nasal decongestant (Pseudoephedrine), combined within an aqueous vehicle or solid excipients. The use of this specific trio is pharmacologically supported for its comprehensive action against congestion and cough.

General Purpose: What Bromadine-DM Aims to Relieve

The general therapeutic purpose of Bromadine-DM is to provide integrated symptomatic relief for the concurrent symptoms of the common cold or seasonal allergies, such as when an individual experiences both a persistent, non-productive cough and pronounced nasal congestion. This is accomplished by the combined actions of its components: Brompheniramine targets allergic responses, Dextromethorphan helps suppress the persistent cough reflex, and Pseudoephedrine works to reduce the nasal swelling that causes congestion. The medicine's overall goal is to manage the discomfort associated with a congested state by addressing the multiple facets of upper respiratory distress with a single systemic treatment.

Regulatory References

  1. DailyMed Drug Label (Brompheniramine, Dextromethorphan, Pseudoephedrine)
  2. Brompheniramine/Dextromethorphan/Pseudoephedrine (Medscape)
Advertisements

What side effects are possible with Bromadine-DM?

Possible Side Effects and Safety Information

The safety profile of Bromadine-DM, a fixed-dose triple-combination product, is described in official regulatory documents based on the known effects of its three active components. Adverse reactions are formally classified by frequency and the body system affected, providing a structured view of potential risks.

Officially Documented Adverse Reactions

The most frequent adverse effects are generally related to the Central Nervous System (CNS) and the anticholinergic properties of the antihistamine component.

Classification Examples of Reactions
Most Frequent Sedation, Drowsiness, Dizziness, Dryness of the mouth, nose, and throat, Thickening of bronchial secretions.
Other Reactions Nervousness, Insomnia, Tremor, Headache, Hypotension, Palpitation, Gastrointestinal disturbances (e.g., nausea, constipation), Skin rash, and Difficult urination.

Serious adverse reactions documented in regulatory text include Convulsions/Seizure (especially in cases of overdosage), severe Hypertension, Cardiac Arrhythmias, and rare Blood Dyscrasias such as Agranulocytosis. The product labeling also notes that the medicine may impair the mental and physical abilities required for performing hazardous tasks, such as driving or operating machinery.

Population-Specific Safety Constraints

The official labeling establishes specific safety constraints for vulnerable populations and pre-existing conditions. Bromadine-DM is Contraindicated in newborns, premature infants, and nursing mothers. Due to the risk of CNS effects, the combination is used with caution in older adults. Use is also restricted in patients with severe Hypertension or Coronary Artery Disease. Furthermore, co-administration with, or use within 14 days of discontinuing, a Monoamine Oxidase Inhibitor (MAOI) is strictly contraindicated.

Advertisements

Overdose and Emergency Response

The official regulatory documents state that a suspected overdose of Bromadine-DM requires that individuals seek immediate medical attention or contact a Poison Control Center immediately due to the potential for severe, documented effects. The combination product’s official profile details a wide spectrum of Central Nervous System (CNS) effects, which can range from severe CNS depression, such as profound drowsiness and loss of muscle coordination (ataxia), to CNS stimulation and the documented risk of convulsive seizures.

Overdosage may also affect the cardiovascular system, with the regulatory documentation specifying the risk of elevated blood pressure (hypertension), rapid heart rate (tachycardia), and serious cardiac arrhythmias. The management steps described in official labeling are supportive and procedural, and may involve interventions like gastric lavage.

Specific pharmacologic measures are described, including the use of Naloxone hydrochloride as potentially valuable for reversing the CNS depression linked to dextromethorphan overdosage. The official profile highlights that overdose in infants and small children carries a uniquely heightened risk for severe outcomes, including hallucinations and death, requiring specialized care and aspiration precautions during certain medical interventions.

Advertisements

Therapeutic Uses of Bromadine-DM

What Bromadine-DM Treats: Main Uses and Benefits

This medication is commonly used to help with symptoms related to coughs and upper respiratory discomfort, including nasal congestion, associated with allergy or the common cold. Bromadine-DM is considered relevant for easing these symptoms when they occur simultaneously.

The product is relevant for conditions involving episodic or fluctuating manifestations, as it helps to address symptom clusters that may become intense or disruptive. It is applied in clinical settings that involve acute symptom patterns, helping to address the simultaneous symptom clusters that often occur together during these episodes. It is relevant for managing symptoms related to inflammatory or irritative states, including nasal congestion, runny nose, sneezing, itchy eyes, and the persistent, non-productive urge to cough.

This supportive therapeutic benefit is commonly used to help with symptoms that interfere with daily functioning, and may help patients cope more steadily with symptom fluctuations.

Quick Fact: Symptomatic Support for Discomfort
Primary Focus: Simultaneous management of congestion, cough, and allergy irritation.
Clinical Scenario: Acute episodes of cold or seasonal allergy flare-ups.
Benefit: Provides support that helps ease the overall symptom burden for temporary functional assistance.

Regulatory References

  1. Label: BROMFEDDM DM- brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide syrup - DailyMed
Advertisements

Eligibility and Restrictions for Use

This section outlines the official eligibility and non-eligibility for Bromadine-DM, based strictly on government regulatory documents.


Populations for Whom Use is Contraindicated

Do not use this medicine if any of the following apply:

  • Hypersensitivity: Known allergy or hypersensitivity to any of the active ingredients (Brompheniramine, Dextromethorphan, or Pseudoephedrine) or any excipients.
  • Concomitant MAOIs: Current use of, or use within 14 days of, taking a Monoamine Oxidase Inhibitor (MAOI).
  • Life Stage: You are a newborn, a premature infant, or a nursing mother.
  • Severe Cardiovascular Disease: Presence of severe hypertension or severe coronary artery disease.

Conditional Use and Restrictions

Use of this medicine requires caution and medical consultation if you have certain pre-existing conditions, including:

  • Chronic Diseases: Bronchial asthma, narrow angle glaucoma, diabetes, or thyroid disease.
  • Gastrointestinal/Urinary Obstruction: Blockage of the stomach/intestines or the urinary bladder neck.
  • Age: Elderly patients may require close monitoring due to increased risk of intolerance and specific side effects.

Age-Related Eligibility

Age Group Eligibility Status Regulatory Note
Newborns/Premature Infants Contraindicated Use is strictly forbidden.
Children (under age 4/6) Not Recommended/Contraindicated Safety and effectiveness have not been established or use is discouraged.
Elderly Patients Conditional Use Use with caution, often requiring medical review.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions documented in official government regulatory information and is strictly descriptive. Bromadine-DM, a combination product, contains an antihistamine (brompheniramine), a sympathomimetic (pseudoephedrine), and a cough suppressant (dextromethorphan), each contributing to the product's overall interaction profile.

Interactions with Monoamine Oxidase Inhibitors (mathbfMAOIs):

Co-administration with mathbfMAOIs is associated with serious, potentially fatal effects, including hyperpyrexia (high fever) and hypotension. mathbfMAOIs are documented to prolong and intensify the anticholinergic effects of the antihistamine component and may also enhance the effects of the sympathomimetic component.

Interactions with Central Nervous System (mathbfCNS) Depressants:

Substances that depress the mathbfCNS, such as alcohol, opiates, tranquilizers, sedatives, and hypnotics, have officially documented additive effects when combined with Bromadine-DM. These effects may be increased, particularly in elderly or debilitated patients.

Interactions Affecting Blood Pressure:

The sympathomimetic component (pseudoephedrine) is documented to potentially reduce the intended therapeutic effects of certain antihypertensive drugs. This is an official pharmacodynamic constraint noted in regulatory documents.

Timing and Restrictions:

Use with mathbfMAOIs should be avoided. The interaction structure necessitates careful selection of co-administered medicines that act on the mathbfCNS or affect blood pressure to manage documented risks of additive effects or therapeutic opposition.

Advertisements

Mechanism of Action

How Bromadine-DM Works: Mechanism of Action

Bromadine-DM operates through three distinct pharmacodynamic mechanisms, targeting key inflammatory, neurological, and autonomic systems simultaneously.


Modulation of Histaminergic and Cholinergic Mediators

Brompheniramine acts as an antagonist at the histamine H1 receptors and, secondarily, at muscarinic acetylcholine receptors. This competitive blockade suppresses histamine-driven increases in vascular permeability and inhibits the cholinergic pathways that regulate glandular secretions. The resulting physiological effect is the suppression of plasma exudation and reduction of glandular fluid output in mucosal tissues.


Central Elevation of the Cough Reflex Threshold

Dextromethorphan exerts a non-opioid modulatory effect on neuronal activity within the medullary cough center in the brainstem, involving the sigma1 receptor. This molecular action modifies the central neurological reflex arc by elevating the necessary threshold for irritant signals to trigger a cough response. The physiological consequence is an increase in the neural threshold of the cough reflex arc against afferent stimuli.


Peripheral Control of Vascular Tone and Edema

Pseudoephedrine utilizes an indirect sympathomimetic mechanism, promoting the release of norepinephrine to activate local alpha1-adrenergic receptors on blood vessels in the nasal and sinus lining. This alpha1 activation causes vasoconstriction, actively reducing blood flow and lowering hydrostatic pressure. The resulting physiological effect is the shrinkage of mucosal membranes due to reduced edema.

Advertisements

Dosage and Administration Information

The administration of Bromadine-DM, an oral triple-combination product, is governed by a precise, age-banded regimen detailed in its official regulatory labeling. The approved route of administration is exclusively oral, and the medication is intended for intermittent, as-needed use for acute periods.

For the standard syrup formulation, the dosing schedule for patients 12 years of age and over is 10 mL (two teaspoonfuls) per dose. This quantity should be repeated no more frequently than every 4 hours.

Age Group Single Dose Volume Maximum Daily Limit
12 years and over 10 mL 6 doses / 24 hours
6 to <12 years 5 mL 6 doses / 24 hours
2 to <6 years 2.5 mL 6 doses / 24 hours
6 months to <2 years Dosage established by a physician 6 doses / 24 hours

The maximum daily intake is strictly limited and must not exceed 6 doses within a 24-hour period for any age group. For infants aged 6 months to 2 years, the official label specifies that the dosage must be established by a physician.

Administration requires the use of a calibrated medical measuring device to ensure volumetric accuracy. The medicine may be taken with or without food. Since use is as needed, a dose should be skipped if the time for the next scheduled dose is imminent, ensuring the minimum 4-hour interval is maintained and that the daily maximum is not exceeded.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Exploring the Combination of Drug A and Drug B

Research has explored whether the combination of Drug A and Drug B was studied in the context of treating Condition Z. These studies focused on the administration of the two drugs concurrently as a single treatment regimen.

  • Studies evaluated data focused on symptom severity and changes over time.
  • Information about usage in the studies focused on the drugs being taken as directed by the clinical investigators.

Primary Clinical Findings

Research has explored this combined treatment in the therapy for Condition Z and examined its impact.

A major study compared outcomes of the combination versus Drug A alone regarding the occurrence of flare-ups.

  • The combination regimen was evaluated for long-term symptom trends compared to monotherapy with Drug A.
  • Another key area of research examined how the combination affected the overall quality of life measures for participants.

Pharmacokinetic and Safety Profile Studies

The study data suggests Drug B was studied for its effect on Drug A, with research examining the combined treatment outcomes. The specific relationship between the drugs remains a subject of ongoing investigation.

  • Studies explored the pharmacokinetic profile; specifically, the research focused on the drugs’ disposition in the body (absorption and metabolism).
  • Safety reporting in the studies did not identify concerns for most patients, but findings were limited in people with severe liver disease.
  • Research examined the overall tolerability of the combination, focusing on the frequency and type of adverse events reported by participants.

Key Studies & References

  1. Clinical Guideline for the Treatment of Condition Z: Section on Combination Therapy
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bromadine-DM (FAQ)


Q: Is Bromadine-DM the same type of medicine as regular Bromadine?

Official documents define Bromadine-DM as a triple-combination product, meaning it contains three active ingredients: Brompheniramine, Dextromethorphan, and Pseudoephedrine. By comparison, 'regular Bromadine' is generally the term used for the single antihistamine component, Brompheniramine, on its own. The combination product is formulated to address a wider range of symptoms simultaneously.

Q: What is the main difference between Bromadine-DM and over-the-counter cough syrups?

Regulatory classifications describe Bromadine-DM as an Antihistamine/Antitussive/Decongestant Combination. This means it is formulated to deliver three distinct actions—targeting allergy, cough, and congestion—in one product. This distinguishes the medicine from many simple cough syrups that may contain only a single active ingredient.

Q: Can Bromadine-DM be taken for a scratchy throat, or only for chest congestion?

The product is officially indicated for the relief of symptoms including cough and nasal congestion. While scratchy throat is not explicitly listed, the antihistamine component (Brompheniramine) works to suppress secretions. These secretions can be a contributing factor to irritation and discomfort in the throat.

Q: How quickly should I expect to notice the effects of Bromadine-DM?

Official pharmacokinetic data indicates that the active components in Bromadine-DM are typically absorbed and measurable in the plasma within 30 to 60 minutes after taking the medicine by mouth. This period indicates the time frame when the components become available in the body to produce an effect.

Q: How long does the typical effect of one dose of Bromadine-DM last?

Official dosing instructions state that a dose should be repeated no more frequently than every 4 hours. This minimum time interval is established based on the therapeutic duration and half-life of the active components to maintain appropriate drug concentrations.

Q: Is Bromadine-DM available without a prescription in some places?

The regulatory status of a drug, such as whether it requires a prescription or is available over-the-counter, is determined by national health authorities. This status is specified in official drug registries, but the designation may vary depending on the country or jurisdiction.

Q: Can Bromadine-DM be used if I am already taking an antidepressant medicine?

Official labeling strictly contraindicates use with Monoamine Oxidase Inhibitors ( MAOIs), which is a specific class of antidepressant. For other types of CNS (central nervous system) active antidepressants, regulatory documents generally advise caution due to the potential for additive effects between the medicines.

Q: Does Bromadine-DM interact with herbal supplements like St. John's Wort?

Official drug documents often include a general warning that the effects of the product may be altered by concomitant use of herbal or dietary supplements. This caution exists to manage the risks associated with interactions that may not have been specifically studied in clinical trials.

Q: Why does the packaging list so many potential side effects for Bromadine-DM?

The list of documented side effects is comprehensive because it incorporates the known adverse reactions of all three active ingredients combined: the antihistamine, the antitussive, and the decongestant. This combination of potential effects contributes to a longer list than what might be seen for a single-ingredient medicine.

Q: Is Bromadine-DM addictive or habit-forming?

Regulatory documents address the abuse potential of the Dextromethorphan component and the specific regulatory restrictions placed on the Pseudoephedrine component in some jurisdictions. These restrictions are in place to control the distribution and monitor the use of these substances.

Q: What is the purpose of the non-medicinal ingredients in Bromadine-DM tablets?

Official documents list non-medicinal ingredients, or excipients, whose primary purpose is to help provide the drug's physical structure, ensure stability, and assist with how the medicine dissolves. These ingredients are necessary to manufacture the product in its final form.

Q: Is there any difference in effect between the liquid and tablet forms of Bromadine-DM?

The official labeling confirms that the same active ingredients and their concentrations per dose are used across different dosage forms, such as liquid and tablet. This is done to deliver the same intended therapeutic effect, and the forms are generally defined as bioequivalent in their systemic action.

Q: Can people with liver or kidney conditions use Bromadine-DM?

The official labeling for all three active components requires that caution or a dose adjustment be considered in patients with pre-existing renal (kidney) or hepatic (liver) impairment. This is necessary because these organs are responsible for the body's processing and clearance of the medicine.

Q: Are there any long-term effects associated with using Bromadine-DM frequently?

This product is officially designated for intermittent, acute, and as-needed use to manage temporary symptoms. Regulatory documents generally do not contain safety data for use beyond the labeled acute duration, as the product is not intended for chronic administration.

Q: Is it true that Bromadine-DM can make certain medical tests inaccurate?

Official labeling indicates that the decongestant component, Pseudoephedrine, is documented to have the potential to cause false-positive results on some screening tests. Specifically, this is noted in relation to tests for amphetamine and methamphetamine.

Q: Does research show a consistent pattern of efficacy for Bromadine-DM?

Clinical research summarized in the regulatory context generally focuses on demonstrating that the medicine is effective for its indicated uses and that the combination provides a comprehensive profile against multiple symptoms. This research supports the official claims made about its therapeutic effects.

Q: Does the time of day I take Bromadine-DM affect how it works?

Official warnings advise caution when taking the product at times that require high mental alertness because drowsiness and sedation are listed as frequent adverse effects. This information suggests that the timing of administration can influence a patient's level of wakefulness and attention.

Q: Can people with diabetes safely use Bromadine-DM liquid formulations?

Official documents indicate that liquid formulations of cold and cough medicines frequently contain sugar or sugar-based excipients to improve taste. The official ingredients list will specify any carbohydrate content that may be a factor for individuals managing blood glucose levels.

Q: Does Bromadine-DM lose effectiveness if used too often?

Regulatory texts define the product for as-needed use only and mandate adherence to minimum dosing intervals. This requirement implicitly discourages the development of tolerance (or less effectiveness) that can sometimes occur with very frequent or excessive use of certain medicines.

Q: Are there any documented cases of Bromadine-DM being associated with mood changes?

The official safety profile for the product documents central nervous system effects associated with the active components. These include reactions like anxiety, restlessness, agitation, and, in misuse or overdose scenarios, hallucinations.

Q: What are the known interactions between Bromadine-DM and common pain relievers?

Regulatory documents include warnings that co-administration of NSAIDs (a common class of pain relievers) with the Pseudoephedrine component may carry a documented small risk of additive cardiovascular effects. There is also a general caution regarding the risk of additive liver toxicity if the pain reliever contains acetaminophen.

Q: Can I take Bromadine-DM if I'm allergic to other cough medicines?

The product is contraindicated for known allergy to any of its specific components. Official guidance notes the potential for cross-reactivity with chemically similar medicines, which is why information regarding all known drug allergies is relevant when discussing the use of this product.

Q: How does the action of Bromadine-DM compare to a simple cough lozenge?

Bromadine-DM is classified as a systemic medicine, meaning its active ingredients work throughout the body to target the cough reflex, nasal tissues, and allergic response. This action is distinct from a cough lozenge, which generally provides a local, surface-soothing effect only on the throat.

Q: Is there a generic version of Bromadine-DM available?

The availability of generic equivalents is a matter of public record maintained by the authorizing regulatory agency, such as the FDA Orange Book. This information can be verified by checking against the product’s listed active ingredients and forms.

Q: Are there any official reports or papers summarizing the safety of Bromadine-DM?

The definitive summary of the product's safety profile, including all documented adverse events, warnings, and contraindications, is contained within the official regulatory labeling issued by national health authorities. These documents are publicly available and collate the necessary safety data.

Advertisements

How should Bromadine-DM be stored and disposed of?

Storage Conditions

Official regulatory labeling requires Bromadine-DM to be stored at Controlled Room Temperature (CRT), maintaining a range between 20 to 25 C (68 to 77 F). The product must be kept tightly closed in a light-resistant container as defined by the USP, and exposure to excessive heat must be avoided to maintain the medicine's stability.

Storage Requirement Specification
Temperature 20 to 25 C (68 to 77 F)
Protection Keep tightly closed; must be light-resistant
Safety Store out of the sight and reach of children

Disposal Instructions

Unused or expired Bromadine-DM should be disposed of by following any specific instructions on the drug's label or by using a community drug take-back program. If these options are unavailable, regulatory guidance advises mixing the medicine with an undesirable substance, such as used coffee grounds, sealing the mixture in a container, and discarding it in the household trash. Identifying information should be scratched off the label before discarding the empty container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bromadine-DM found in:

A-Z Index: